$LNAI

Lunai Bioworks Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Suite 906 Los Angeles, CA

LNAI chart

What traders are saying about $LNAI

Latest posts

Lunai Bioworks Inc. news

Lunai Bioworks Inc. key financials

USD2026202520242023
Revenue$51,992–––
Net income-$3.6M-$178.0M-$88.4M-$39.7M
Diluted EPS$-1.06$-86.27$-0.91$-0.71
Total assets (year end)–$6.7M$111.3M$58.0M
Cash and equivalents (year end)–$491,645$311,764$243,980

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Lunai Bioworks Inc.

Ticker
LNAI (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Suite 906 Los Angeles, CA
Incorporated in
DE
Fiscal year end
June 30
SEC CIK
1527728
Former names
RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc

Frequently asked questions

What exchange is Lunai Bioworks Inc. listed on?

Lunai Bioworks Inc. trades on the Nasdaq under the ticker symbol LNAI.

What industry is Lunai Bioworks Inc. in?

Lunai Bioworks Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Lunai Bioworks Inc. headquartered?

Lunai Bioworks Inc.'s business address on file with the SEC is in Suite 906 Los Angeles, CA.

When does Lunai Bioworks Inc.'s fiscal year end?

Lunai Bioworks Inc.'s fiscal year ends on June 30.

How much revenue did Lunai Bioworks Inc. report?

Lunai Bioworks Inc. reported $51,992 in revenue for calendar year 2026, according to its SEC filings.